Different Therapeutic Interventions And Mechanisms of Action of Antisickling Agents Currently in Use in Sickle Cell Disease Management
Sickle cell disease is a genetic disorder caused by sickle haemoglobin. In many forms of the disease, the red blood cells can change shape upon deoxygenation due to abnormal sickle haemoglobin polymerisation. The haemoglobin proteins stick to each other, causing the cell to have a rigid surface and...
Main Authors: | Ngozi Awa Imaga, Oluwole Taiwo |
---|---|
Format: | Article |
Language: | English |
Published: |
European Medical Journal
2017-08-01
|
Series: | European Medical Journal Hematology |
Subjects: | |
Online Access: | https://www.emjreviews.com/hematology/article/different-therapeutic-interventions-and-mechanisms-of-action-of-antisickling-agents-currently-in-use-in-sickle-cell-disease-management/ |
Similar Items
-
Fetal Hemoglobin is Associated with Peripheral Oxygen Saturation in Sickle Cell Disease in Tanzania
by: Siana Nkya, et al.
Published: (2017-09-01) -
Fetal hemoglobin modifies the disease manifestation of severe Plasmodium falciparum malaria in adult patients with sickle cell anemia.
by: Prasanta Purohit
Published: (2016-11-01) -
Agentes indutores da síntese de hemoglobina fetal Fetal hemoglobin inducing factors
by: Maria Stella Figueiredo
Published: (2007-09-01) -
Pharmacogenomics of sickle cell disease: steps toward personalized medicine
by: Husain M, et al.
Published: (2017-10-01) -
Erythroid Adhesion Molecules in Sickle Cell Anaemia Infants: Insights Into Early Pathophysiology
by: Valentine Brousse, et al.
Published: (2015-02-01)